What antibiotics are used to treat cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for Cellulitis

For typical uncomplicated cellulitis, a 5-day course of an antibiotic active against streptococci is the recommended first-line treatment, with options including penicillin, amoxicillin, dicloxacillin, cephalexin, or clindamycin. 1

Classification and Antibiotic Selection

Non-purulent Cellulitis (No drainage, exudate, or abscess)

  • First-line therapy: β-lactam antibiotics targeting streptococci 1

    • Penicillin
    • Amoxicillin
    • Dicloxacillin
    • Cephalexin (500 mg four times daily)
    • Amoxicillin-clavulanate
  • Duration: 5 days is sufficient if clinical improvement occurs; extend if no improvement 1

  • For penicillin-allergic patients: Clindamycin (300-450 mg three times daily) 1

Purulent Cellulitis (With drainage or exudate)

  • First-line therapy: Empiric coverage for CA-MRSA pending culture results 1

    • Clindamycin (strong evidence) 1
    • Trimethoprim-sulfamethoxazole (TMP-SMX) 1
    • Doxycycline or minocycline 1
    • Linezolid (for severe cases) 1
  • Duration: 5-10 days, individualized based on clinical response 1

When Both Streptococcal and MRSA Coverage is Needed

  • Options:
    • Clindamycin alone 1
    • TMP-SMX or tetracycline plus a β-lactam (e.g., amoxicillin, cephalexin) 1
    • Linezolid alone 1

Hospitalized Patients with Complicated SSTI

  • Intravenous options:

    • Vancomycin 1, 2
    • Linezolid 600 mg twice daily 1
    • Daptomycin 4 mg/kg once daily 1
    • Telavancin 10 mg/kg once daily 1
    • Clindamycin 600 mg three times daily 1
  • Duration: 7-14 days based on clinical response 1

Special Considerations

When to Consider MRSA Coverage

  • Penetrating trauma, especially from illicit drug use 1
  • Purulent drainage 1
  • Evidence of MRSA infection elsewhere 1
  • Nasal colonization with MRSA 1
  • Injection drug use 1
  • Systemic inflammatory response syndrome (SIRS) 1
  • Athletes, children, men who have sex with men, prisoners, military recruits, residents of long-term care facilities 3

When to Obtain Cultures

  • Patients with malignancy on chemotherapy 1
  • Neutropenia 1
  • Severe cell-mediated immunodeficiency 1
  • Immersion injuries 1
  • Animal bites 1
  • Severe systemic features (high fever, hypotension) 1
  • Patients treated with antibiotics who are not responding 1

Adjunctive Measures

  • Elevation of the affected area to promote drainage of edema 1
  • Treatment of predisposing conditions (tinea pedis, venous eczema, trauma) 1
  • Systemic corticosteroids (prednisone 40 mg daily for 7 days) may be considered in non-diabetic adults 1

Common Pitfalls to Avoid

  1. Overuse of broad-spectrum antibiotics: Studies show narrow-spectrum antibiotics targeting streptococci are effective for typical cellulitis 4

  2. Unnecessary MRSA coverage: MRSA is an unusual cause of typical non-purulent cellulitis; a study showed β-lactam therapy was successful in 96% of cellulitis cases 1

  3. Prolonged treatment courses: 5 days is as effective as 10 days for uncomplicated cellulitis if clinical improvement occurs 1

  4. Failure to address predisposing factors: Examine interdigital toe spaces for fissuring or maceration that may harbor pathogens 1

  5. Misdiagnosis: Many clinical conditions can mimic cellulitis; consider alternative diagnoses if no improvement with appropriate therapy 3

By following these evidence-based guidelines for antibiotic selection based on the type of cellulitis and patient risk factors, clinicians can effectively treat cellulitis while practicing appropriate antibiotic stewardship.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.